Term Name: linsitinib
Synonyms: ASP-7487, cis-3-[8-amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol, cis-3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol, linsitinib, linsitinibum, OSI 906, OSI 906AA, OSI-906, OSI-906AA, OSI906
Definition: An imidazopyrazine that is imidazo[1,5-a]pyrazine substituted by 2-phenylquinolin-7-yl, cis-3-hydroxy-3-methylcyclobutyl, and amino groups at positions 1, 3, and 8, respectively. It is dual inhibitor of the IGF-1 receptor and insulin receptor (IC50 = 35 and 75 nM, respectively) that was previously in clinical development for the treatment of cancer and thyroid eye disease.
Ontology: ChEBI [CHEBI:91402]  ( EBI )

Relationships
is a type of: aromatic amine benzenes cyclobutanes imidazopyrazine quinolines tertiary alcohol
has_role: antimycobacterial drug antineoplastic agent apoptosis inducer insulin-like growth factor receptor 1 antagonist